ACTINIUM PHARMACEUTICALS, INC.
Income Statement
| Line Item | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | — | — | — | — | — | — | — |
| Cost of Revenue | $0 | — | — | — | — | — | — | — |
| Gross Profit | $0 | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-26.1K | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | $-6.4K | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $-834 | — | — | — | — | — | — | — |
| Net Income | $-467.3K | $-3.4M | $-5.6M | $-5.6M | $-6.1M | $-4.6M | $-5.7M | $-3.5M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $0.01 | — | — | — | — | — | — | — |
| EPS (Diluted) | $0.01 | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 11.2M | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | 11.2M | — | — | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |